Reducing Heart Failure Re-admissions by Enhancing Sleep Apnea Treatment Adherence
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Congestive Heart Failure
- Sponsor
- University of Pennsylvania
- Enrollment
- 146
- Primary Endpoint
- Number of Participants Adhering to Positive Airway Pressure (PAP)
- Status
- Completed
- Last Updated
- 5 years ago
Overview
Brief Summary
Sleep apnea, characterized by abnormal breathing at night, is often untreated in patients with heart failure. Helping patients to effectively use the most common form of treatment for sleep apnea, positive airway pressure therapy, can improve their heart function. This can reduce the likelihood that the patient will be re-admitted to the hospital. AirCareLabs has developed an innovative solution that allows patients to communicate with health care providers 24 hours a day, thus allowing them to get the help they need to effectively use positive airway pressure and thereby reduce the risk of being re-admitted to the hospital.
Investigators
Nalaka Gooneratne
Associate Professor
University of Pennsylvania
Eligibility Criteria
Inclusion Criteria
- •Congestive heart failure and sleep apnea
Exclusion Criteria
- •Cognitive impairment
Outcomes
Primary Outcomes
Number of Participants Adhering to Positive Airway Pressure (PAP)
Time Frame: one month
PAP adherence will be measured from the PAP unit (which monitors nightly hours of use and records this data; this is the standard of care clinical practice approach used currently by health care providers to monitor PAP use) and will be reported as Number of Participants who Adhered to Positive Airway Pressure (PAP) Treatment (adherence defined as \>4 hours of use per night on average across the 30 day period). For example, if 5 subjects used PAP for more than 4 hours per night on average across the 30 day period, then the number of adherent participants is 5.